ChemicalBook >> CAS DataBase List >>Ozagrel hydrochloride hydrate

Ozagrel hydrochloride hydrate

CAS No.
78712-43-3
Chemical Name:
Ozagrel hydrochloride hydrate
Synonyms
OZAGREL HYDROCHLORIDE;Vega;Ozag;Domenan;OKY-046 HCl;(e)-ohydrat;OZAGREL HCL;OzagrelHcl99%;oky046hydrochloride;Ozagrel Impurity 44
CBNumber:
CB4765488
Molecular Formula:
C13H13ClN2O2
Molecular Weight:
264.71
MDL Number:
MFCD00911569
MOL File:
78712-43-3.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-16 07:06:08
Product description Number Pack Size Price
Ozagrel hydrochloride hydrate ≥98% (HPLC), solid O1385 5mg $124
Ozagrel hydrochloride hydrate ≥98% (HPLC), solid O1385 25mg $354
Ozagrel Hydrochloride Hydrate >98.0%(HPLC)(T) O0419 1g $32
Ozagrel Hydrochloride Hydrate >98.0%(HPLC)(T) O0419 5g $94
Ozagrel hydrochloride FO39683 0.25kg $150
More product size

Ozagrel hydrochloride hydrate Properties

Melting point 214-217°
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
solubility H2O: soluble
form solid
color white to off-white
Water Solubility H2O: soluble
Merck 14,6980
Stability Stable for 2 years from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 1 month.
InChI 1S/C13H12N2O2.ClH.H2O/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;;/h1-8,10H,9H2,(H,16,17);1H;1H2/b6-5+;;
InChIKey OWIZTYOMGVTSDP-TXOOBNKBSA-N
SMILES O.Cl.OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1
CAS DataBase Reference 78712-43-3(CAS DataBase Reference)
FDA UNII W222U960HS
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P301+P312-P302+P352-P304+P340-P305+P351+P338
PPE Eyeshields, Gloves, type N95 (US)
RIDADR  3077
WGK Germany  2
RTECS  UD3380000
HS Code  29332900
Storage Class 11 - Combustible Solids

Ozagrel hydrochloride hydrate price More Price(62)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich O1385 Ozagrel hydrochloride hydrate ≥98% (HPLC), solid 78712-43-3 5mg $124 2026-04-30 Buy
Sigma-Aldrich O1385 Ozagrel hydrochloride hydrate ≥98% (HPLC), solid 78712-43-3 25mg $354 2022-05-15 Buy
TCI Chemical O0419 Ozagrel Hydrochloride Hydrate >98.0%(HPLC)(T) 78712-43-3 1g $32 2026-04-30 Buy
TCI Chemical O0419 Ozagrel Hydrochloride Hydrate >98.0%(HPLC)(T) 78712-43-3 5g $94 2026-04-30 Buy
Biosynth FO39683 Ozagrel hydrochloride 78712-43-3 0.25kg $150 2026-06-04 Buy
Product number Packaging Price Buy
O1385 5mg $124 Buy
O1385 25mg $354 Buy
O0419 1g $32 Buy
O0419 5g $94 Buy
FO39683 0.25kg $150 Buy

Ozagrel hydrochloride hydrate Chemical Properties,Uses,Production

Description

Ozagrel HCl (78712-43-3) is a potent and selective inhibitor of thromboxane A2 (TXA2) synthetase (IC50 = 4 nM). It does not inhibit prostacyclin (PGI2) synthase, cyclooxygenase, or PGE2 isomerase (IC50 > 1 mM)[1]. Ozagrel HCl inhibits platelet aggregation in vitro[2] and arachidonate-induced arterial contraction in vivo. It protects against arachidonate-induced sudden death in rabbits[3] and alleviates liver injury induced by acetaminophen overdose in mice[4].

History

Ozagrel hydrochloride was initially developed jointly by Ono Pharmaceutical Co., Ltd. and Kissei Pharmaceutical Co., Ltd. in Japan. Approved for marketing in Japan in 1988, it became the world's first commercially available potent thromboxane A2 (TXA2) synthase inhibitor. This medication is primarily indicated for the treatment of patients with ischaemic cerebrovascular disease, as it exhibits dual effects of inhibiting platelet aggregation and dilating blood vessels, thereby effectively preventing thrombus formation.

Uses

Ozagrel Hydrochloride is a selective thromboxane A2 synthase inhibitor, which alleviates liver injury induced by acetaminophen overdose in mice.

Definition

ChEBI: Ozagrel hydrochloride is an organic molecular entity.

Synthesis

The main synthetic methods of ozagrel hydrochloride are as follows: 1) take p-toluylaldehyde as raw material, get methyl or ethyl p-toluyl cinnamate by Claisen condensation or by Knoevenagl reaction and then esterification, get alkyl p-bromomethyl cinnamate by bromination, get alkyl p-bromomethyl cinnamate by N-alkylation with imidazole or N-acyl imidazole under the action of strong alkaline and finally hydrolyze it to get ozagrel hydrochloride under alkaline heating condition or hydrolysis to get ozagrel hydrochloride by bromination first and then N-alkylation of p-toluylaldehyde. hydrolysis under alkaline heating conditions to obtain ozagrel hydrochloride, or p-methylbenzaldehyde is first brominated and then N-alkylated, and finally undergoes a Knoevenagl reaction to obtain ozagrel hydrochloride. The acid-binding agents used in this method, sodium hydride, 1-substituted imidazole, N-bromosuccinimide (NBS), are expensive, and there is also the possibility of using corrosive and toxic bromine, carbon tetrachloride, unfriendly to the environment, unsuitable for industrial production; p-carboxymethylbenzaldehyde as a raw material, through a multistep reaction to produce ozagrel hydrochloride, which has a long synthetic route, and needs to be separated by column chromatography, the operation of which is cumbersome and not suitable for industrial production of ozagrel hydrochloride. This method has a long synthetic route and requires column chromatographic separation, which is cumbersome and not suitable for the industrial production of ozagrel hydrochloride. (iii) Ozagrel hydrochloride was obtained by condensation, hydrolysis and acidification of mimosine and methyl 4-bromomethylcinnamate as raw materials under the condition of sodium hydride and N,N-dimethylformamide as solvent. In this synthetic route, the raw material methyl 4-bromomethylcinnamate is more expensive, and if prepared, it has to be re-esterified with p-methylcinnamic acid brominated with NBS, which is the more expensive brominated reagent. The use of sodium hydride and DMF both add to the cost, and sodium hydride is dangerous, and DMF is difficult to remove as a high boiling solvent.

IC 50

TXA2/TP

References

[1] SEIJI HIRAKU . Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046)[J]. Japanese journal of pharmacology, 1986, 41 3: Pages 393-401. DOI:10.1254/jjp.41.393
[2] JUN NAITO . Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets[J]. European journal of pharmacology, 1983, 91 1: Pages 41-48. DOI:10.1016/0014-2999(83)90359-x
[3] LEE C. EDMONDS  Allan M L. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death[J]. Life sciences, 1984, 35 17: Pages 1763-1768. DOI:10.1016/0024-3205(84)90273-x
[4] YOSHIRO TOMISHIMA. Ozagrel hydrochloride, a selective thromboxane A₂ synthase inhibitor, alleviates liver injury induced by acetaminophen overdose in mice.[J]. BMC Gastroenterology, 2013, 13: 21. DOI:10.1186/1471-230x-13-21

Ozagrel hydrochloride hydrate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 214)Suppliers
Supplier Tel Email Country ProdList Advantage
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29766 58
CONIER CHEM AND PHARMA LIMITED
sales@conier.com China 49906 58
SIMAGCHEM CORP
+86-5922680277 +86-13806087780 sale@simagchem.com China 17339 58
TargetMol Chemicals Inc.
+1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Dideu Industries Group Limited
+8617392712697 1022@dideu.com China 29091 58
AFINE CHEMICALS LIMITED
+86-571-85134551 +86-18958018566 info@afinechem.com China 15045 58
BOC Sciences
16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
Dayang Chem (Hangzhou) Co.,Ltd.
+86-0571-88938639 17705817739 info@dycnchem.com China 52693 58
changzhou huayang technology co., ltd
+8615250961469 2571773637@qq.com China 9628 58
TargetMol Chemicals Inc.
+1-781-999-5354; support@targetmol.com United States 38999 58

View Lastest Price from Ozagrel hydrochloride hydrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Ozagrel hydrochloride pictures 2026-07-15 Ozagrel hydrochloride
78712-43-3
$44.00-107.00 99.80% 10g TargetMol Chemicals Inc.
Ozagrel hydrochloride pictures 2021-07-02 Ozagrel hydrochloride
78712-43-3
$10.00-15.00 1KG 99%+ HPLC Zhuozhou Wenxi import and Export Co., Ltd
Ozagrel hydrochloride pictures 2019-07-06 Ozagrel hydrochloride
78712-43-3
$1.00 1kg 99% Career Henan Chemical Co

Ozagrel hydrochloride hydrate Spectrum

OKY-046, (E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrate hydrochloride Ozagrel hydrate hydrochloride Domenan OKY-046 HCl Vega Ozagrel hydrochloride hydrate,(E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrochloride hydrate, OKY-046 (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid,hydrochloride (1:1) (E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrochloride hydrate Hydrochloride Ozagrel (E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride Ozagrel hydrochloride hydrate, 99%, a selective thromboxane A(2) synthetase inhibitor (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid hydrochloride Ozag (e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoicacidhydrochloridehydra (e)-ohydrat 2-propenoicacid,3-(4-(1h-imidazol-1-ylmethyl)phenyl)-,monohydrochloride,mon oky046hydrochloride oky-046hydrochloride OZAGREL HYDROCHLORIDE HYDRATE OzagrelHcl99% OzagrelHclC13H12N2O2.Hcl (e)-3-[4-(imidazol-1-ylmethyl)phenyl]propenoic acid hydrochloride (e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic acid hydrochloride OZAGREL HCL (2E)-3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2-PROPENOIC ACID HYDROCHLORIDE OzagrelHydrochlorideHydrate> Ozagrel Impurity 44 (E)-Ozagrel hydrochloride trans-4-[(1-Imidazolyl)methyl]cinnamic Acid Hydrochloride Ozagrel hydrochloride USP/EP/BP Ozagrel HCl (OKY046 HCl Ozagrel hydrochloride, 10 mM in DMSO Ozagrel HCl - Bio-X ? OZAGREL HYDROCHLORIDE 78712-43-3 C13H12N2O2ClH C13H12N2O2HCl C13H12N2O2HClxH2O C13H12N2O2ClHH2O R to Z Thromboxane A2 synthase Enzyme Inhibitors by Enzyme Enzyme Inhibitors Biochemicals and Reagents BioChemical Enzymes, Inhibitors, and Substrates Inhibitors Piperidones ,Piperidines ,Homopiperidines Cardiovascular